Fred Hassan - 02 Nov 2026 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Nov 2026, 17:12:37 UTC
Prior SEC filing
04 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kyle Nelson, attorney-in-fact
Filing notes and source

Key filing fact

Fred Hassan filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 04 Nov 2026.

Key facts

  • This page summarizes Fred Hassan's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 17:12.

Change

  • Previous filing in this sequence was filed on 04 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001110744 Primary reporting owner

Hassan Fred

Relationship
Director
Address
41 S. RIO GRANDE ST., SALT LAKE CITY
Signature
/s/ Kyle Nelson, attorney-in-fact
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXRX transaction

Class A Common Stock

Award

Transaction value
Shares
+156,658
Change %
Price
$0.000000*
Shares after
156,658
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .